North Dartmouth, MANCT05227053Now EnrollingIRB Ready

Paroxysmal Atrial Fibrillation Clinical Trial in North Dartmouth, MA

Access cutting-edge paroxysmal atrial fibrillation treatment through this clinical trial at a research site in North Dartmouth. Study-provided care at no cost to qualified participants.

Sponsored by Medtronic Cardiac Ablation Solutions

Quick Self-Assessment

See if you qualify for this North Dartmouth location

Preparing your pre-screening questions…

Expert Care in North Dartmouth

Access paroxysmal atrial fibrillation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related paroxysmal atrial fibrillation treatment provided free

Apply for This North Dartmouth Location

Check if you qualify for this paroxysmal atrial fibrillation clinical trial in North Dartmouth, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to North Dartmouth

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit North Dartmouth site if eligible
  4. 4Begin participation

About This Paroxysmal Atrial Fibrillation Study in North Dartmouth

The STOP AF First PAS is a prospective, global, multi-center, observational trial.

Sponsor: Medtronic Cardiac Ablation Solutions

Who Can Participate

Inclusion Criteria

Subject has been diagnosed with symptomatic paroxysmal AF
Subject is ≥ 18 years of age or minimum age as required by local regulations
Planned pulmonary vein isolation (PVI) procedure using the commercially available Arctic Front™ cardiac cryoablation catheter System.
Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements

Exclusion Criteria

History of AF treatment with a class I or III antiarrhythmic drug, including sotalol, with the intention to prevent an AF recurrence1 . Subjects under the following conditions may be included in the study:
Temporary treatment with a class I or III AAD (treatment at a therapeutic dose for a period of \<4 weeks prior to the index PVI procedure)
Recent treatment with a class I or III AAD (within 6 months of the index PVI procedure) at a dose below therapeutic threshold according to the AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation
A subject who has received a chemical cardioversion may be included in the study. This includes a chemical cardioversion prior to enrollment and between enrollment and ablation.
Subject has had a prior atrial ablation (except for cavo-tricuspid isthmus (CTI) ablation for AFL)
Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager
Subject with exclusion criteria required by local law

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in North Dartmouth?

Yes, this clinical trial (NCT05227053) has an active research site in North Dartmouth, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Paroxysmal Atrial Fibrillation Treatment Options in North Dartmouth, MA

If you're searching for paroxysmal atrial fibrillation treatment options in North Dartmouth, MA, this clinical trial (NCT05227053) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our North Dartmouth research site is actively enrolling participants for this clinical trial. You'll receive care from experienced paroxysmal atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all paroxysmal atrial fibrillation clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in North Dartmouth, MA

See all atrial fibrillation clinical trials recruiting in North Dartmouth — not just this study.

Browse Atrial Fibrillation Trials in North Dartmouth →

Browse More Trials by Condition

Atrial Fibrillation TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in North Dartmouth?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · North Dartmouth, MA